Evidence supporting the use of: T4D-myoviridae
For the health condition: Infection (viral)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

T4D-myoviridae refers to a group of lytic bacteriophages, specifically the T4 phage, which infects and destroys certain bacterial hosts (most notably Escherichia coli). The use of T4D-myoviridae and similar bacteriophages in combating infections—especially those caused by antibiotic-resistant bacteria—has a robust scientific foundation, primarily in the context of bacterial, not viral, infections. Phage therapy has been studied for nearly a century, with a resurgence in interest due to the rise of multidrug-resistant bacteria. T4 phages are well-characterized, and their genomes have been sequenced in detail, enabling the development of targeted therapies.

However, it is important to clarify that T4D-myoviridae are not used to treat viral infections; rather, they are themselves viruses that infect bacteria (bacteriophages). Their therapeutic application is in treating bacterial infections, not viral ones. Studies in animal models and some compassionate use clinical cases have demonstrated the efficacy of T4-like phages in reducing bacterial load and improving outcomes in severe infections. The evidence base continues to expand, with several ongoing clinical trials.

In summary, while there is strong scientific support for the use of T4D-myoviridae in treating bacterial infections (evidence rating 4/5), there is no evidence for its use in treating viral infections, as bacteriophages do not affect viruses that infect humans. Any suggestion of their use for viral infection is a misunderstanding of their biology.

More about T4D-myoviridae
More about Infection (viral)

Other health conditions supported by T4D-myoviridae

Infection
Infection (bacterial)
Infection (viral)

Products containing T4D-myoviridae